RECRUITINGPhase 4INTERVENTIONAL
Stellate Ganglion Block
Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study
About This Trial
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.
Who Should NOT Join This Trial:
- Patients who have an exclusion to regional anesthesia.
- Patients who have exclusion to stellate blockade.
- Patients who are pregnant assessed via self-report or pregnancy test if they have taken one
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.
Exclusion Criteria:
* Patients who have an exclusion to regional anesthesia.
* Patients who have exclusion to stellate blockade.
* Patients who are pregnant assessed via self-report or pregnancy test if they have taken one
Treatments Being Tested
DRUG
0.5% bupivacaine
an ultrasound guided left stellate ganglion block with 5 mL of 0.5% bupivacaine
OTHER
Saline
an ultrasound guided left stellate ganglion block with 5 mL of saline
Locations (1)
University of Minnesota
Minneapolis, Minnesota, United States